MHRA approves Comirnaty JN.1 COVID-19 vaccine for adults and children from infancy

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 24 July, approved an adapted Pfizer/BioNTech COVID-19 vaccine (Comirnaty) that targets the JN.1 COVID-19 subvariant.

Follow this news feed: